Taxol News and Research

RSS
Taxol is a drug used to treat breast cancer, ovarian cancer, and AIDS-related Kaposi sarcoma. It is also used together with another drug to treat non-small cell lung cancer. Taxol is also being studied in the treatment of other types of cancer. It blocks cell growth by stopping cell division and may kill cancer cells. It is a type of antimitotic agent. Also called paclitaxel.
New technique allows cells to make terpenes

New technique allows cells to make terpenes

Power of taxane-based chemotherapy drugs may be potentially underestimated

Power of taxane-based chemotherapy drugs may be potentially underestimated

Scientists discover new anti-cancer and anti-metastatic molecule

Scientists discover new anti-cancer and anti-metastatic molecule

International Congress on Natural Products Research to be held in New York City

International Congress on Natural Products Research to be held in New York City

Salk scientists' discovery explains how a class of chemotherapy drugs works

Salk scientists' discovery explains how a class of chemotherapy drugs works

Researchers test nanoscale carbon clusters for cancer chemotherapy

Researchers test nanoscale carbon clusters for cancer chemotherapy

Combination of lapatinib and trastuzumab more effective in treating HER2-positive breast cancer

Combination of lapatinib and trastuzumab more effective in treating HER2-positive breast cancer

New anti-tumor compounds show promise for hard-to-treat cancers

New anti-tumor compounds show promise for hard-to-treat cancers

Plant world has great potential as a source of new medicines, says NYBG scientist

Plant world has great potential as a source of new medicines, says NYBG scientist

Suppressing STARD9 protein could be a novel strategy to fight cancers

Suppressing STARD9 protein could be a novel strategy to fight cancers

Researchers pinpoint cancer-fighting potential in bat plant

Researchers pinpoint cancer-fighting potential in bat plant

Scientists achieve major step toward goal of producing synthetic Taxol

Scientists achieve major step toward goal of producing synthetic Taxol

Merrimack begins MM-121 Phase 2 combination trial in HER2-negative breast cancer

Merrimack begins MM-121 Phase 2 combination trial in HER2-negative breast cancer

Preclinical studies shows EmPAC more effective than Taxol

Preclinical studies shows EmPAC more effective than Taxol

FDA grants Fast Track designation for DARA's KRN5500 neuropathic pain relief drug

FDA grants Fast Track designation for DARA's KRN5500 neuropathic pain relief drug

Excillum receives R&D 100 Award for liquid metal x-ray source

Excillum receives R&D 100 Award for liquid metal x-ray source

Controversy over F.D.A.-Avastin decision to reignite June 28-29 with new round of hearings

Controversy over F.D.A.-Avastin decision to reignite June 28-29 with new round of hearings

Positive interim results from CTI's OPAXIO-TMZ phase II trial on malignant brain tumors presented at ASCO

Positive interim results from CTI's OPAXIO-TMZ phase II trial on malignant brain tumors presented at ASCO

Final analysis of AVEO's tivozanib Phase 2 trial on kidney cancer patients presented at ASCO 2011

Final analysis of AVEO's tivozanib Phase 2 trial on kidney cancer patients presented at ASCO 2011

NCNPR and Cancer Institute in Jackson partner for anti-cancer drug research

NCNPR and Cancer Institute in Jackson partner for anti-cancer drug research